Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-027824
Filing Date
2025-02-26
Accepted
2025-02-26 16:32:42
Documents
81
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vktx-20241231.htm   iXBRL 10-K 3237086
2 EX-10.10 vktx-ex10_10.htm EX-10.10 133306
3 EX-10.11 vktx-ex10_11.htm EX-10.11 212504
4 EX-10.12 vktx-ex10_12.htm EX-10.12 39160
5 EX-10.16 vktx-ex10_16.htm EX-10.16 223159
6 EX-19 vktx-ex19.htm EX-19 159198
7 EX-21.1 vktx-ex21_1.htm EX-21.1 2749
8 EX-23.1 vktx-ex23_1.htm EX-23.1 3970
9 EX-31.1 vktx-ex31_1.htm EX-31.1 16984
10 EX-31.2 vktx-ex31_2.htm EX-31.2 16964
11 EX-32.1 vktx-ex32_1.htm EX-32.1 13360
12 GRAPHIC img5525986_0.jpg GRAPHIC 16820
13 GRAPHIC img198686603_0.jpg GRAPHIC 19797
14 GRAPHIC img199610124_0.jpg GRAPHIC 19797
15 GRAPHIC img254190739_0.jpg GRAPHIC 85093
16 GRAPHIC img254190739_1.jpg GRAPHIC 84039
  Complete submission text file 0000950170-25-027824.txt   13524207

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vktx-20241231.xsd EX-101.SCH 1371940
83 EXTRACTED XBRL INSTANCE DOCUMENT vktx-20241231_htm.xml XML 2405934
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37355 | Film No.: 25670673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)